Roles of hepatic atypical protein kinase C hyperactivity and hyperinsulinemia in insulin‐resistant forms of obesity and type 2 diabetes mellitus
Abstract Diet‐induced obesity, the metabolic syndrome, type 2 diabetes (DIO/MetS/T2DM), and their adverse sequelae have reached pandemic levels. In mice, DIO/MetS/T2DM initiation involves diet‐dependent increases in lipids that activate hepatic atypical PKC (aPKC) and thereby increase lipogenic enzy...
Main Authors: | Mini P. Sajan, Barbara C. Hansen, Mildred Acevedo‐Duncan, Mark S. Kindy, Denise R. Cooper, Robert V. Farese |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.54 |
Similar Items
-
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
by: Anna Maria Fulghesu, et al.
Published: (2021-07-01) -
The importance of pathological insulin resistance and hyperinsulinemia in the pathogenesis of preeclampsia
by: I. S. Lipatov, et al.
Published: (2020-11-01) -
Hyperinsulinemia Influences the Short-Term Efficiency of Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Insulin Resistance
by: Yue Z, et al.
Published: (2023-06-01) -
The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
by: Nadia B. Pateguana, et al.
Published: (2019-07-01) -
The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFκB in obesity
by: Mini P. Sajan, et al.
Published: (2009-06-01)